Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial

Abstract

Background The Mediterranean diet is associated with the prevention of diabetes, cardiovascular disease, and cancer, all of which are linked to intestinal barrier impairment. Objectives Here, we hypothesize that the Mediterranean diet, possibly via the induction of short-chain fatty acids (SCFAs), improves intestinal barrier integrity. Furthermore, we aim to establish novel personalized nutrition advice based on machine learning algorithms. Methods We studied 260 women with intestinal barrier impairment. The women were allocated to follow either a Mediterranean diet or a control diet for 3 mo. Intestinal permeability was assessed by measuring lipopolysaccharide binding protein (LBP) in plasma and zonulin in feces. SCFA concentrations were analyzed in feces. Bi- and multivariate analyses and machine learning algorithms (random forest classification) were conducted. Results Particularly in the intervention group, adherence to the Mediterranean diet increased, whereas plasma LBP and fecal zonulin concentrations decreased (all q < 0.001 for the intervention group, all q < 0.1 for control group). In the intervention group, fecal SCFA concentrations increased (propionate + 19%; butyrate + 44%; both q < 0.001). Multivariate analyses showed that adherence to the Mediterranean diet was associated with SCFA concentrations (all q < 0.001) and inversely associated with LBP and zonulin concentrations (all q < 0.02). Mediation analyses identified propionate and butyrate as the key mechanistic link between diet and intestinal permeability integrity. Accordingly, using baseline SCFA data, we could predict the effect of the Mediterranean diet on intestinal permeability using a machine learning algorithm (receiver operating characteristic AUC: 0.78–0.96). Conclusions Our data suggest that SCFAs are key mediators for the relation between diet and gut health. Assessment of SCFAs may form a basis for personalized nutrition in future clinical care. These results need to be verified in larger studies powered for this purpose, comprising different study populations. The trial was registered at clinicaltrials.gov as NCT02087592 and NCT02516540.

Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review

“…Although a number of evidences, mainly coming from population-based observational studies, support a protective effect of MD against cardiovascular disease, stroke, metabolic disorders, several types of cancer, allergic diseases and Parkinson's and Alzheimer's disease (64)(65)(66)(67) .…”

Identification of Human Gut Microbiome Associated with Enterolignan Production

“…For example, the efficacy of dietary barley intake on dyslipidemia could be discriminated by gut microbiome−based random forest classification [55]. Short−chain fatty acids produced from dietary fiber were elucidated as key mediators of health benefits of the Mediterranean diet through a random forest classification analysis [13]. As shown in these and our current studies, machine learning−based approach may be useful to predict the efficacy of dietary nutrients for each subject, which leads to the realization of precision nutrition.…”

“…A random forest regression analysis of 16S ribosomal RNA data identified the gut microbiome maturity of malnourished children [11] and these results were used to provide complementary food to children [12]. Productivity of short−chain fatty acids from dietary fiber was elucidated as a key factor of health benefits of the Mediterranean diet through a random forest classification analysis [13]. As such, machine learning−based evaluation system, especially random forest, have potential to predict the health efficacy of dietary nutrients whose metabolism is dependent on gut microbiome.…”

Relationships Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease: Indication from Gut Microbiota Alterations

“…Butyricicoccus and Faecalibacterium were the two top genera which worth mentioning, since they were also negatively correlated with RBD-related clinical features (RBD-HK), indicating their close relationship with RBD or RBD-speci c. Noteworthly, the reduction of Faecalibacterium is also compatible with the previous Japanese study and sleep disturbance in psychiatric disorder patients, which enhanced the explanatory evidence for its relation to RBD. Targeting these two genera may be an effective treatment paradigm for individuals with RBD by dietary supplementation, such like the Mediterranean diet 30 .…”